Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BWAY vs ACOM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BWAY Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

BWAY Overall Winner 6-Pillar Tally: BWAY 5 – 0 ACOM (1 Tie) Matrix Metrics: BWAY 7 – 3 ACOM

As of Nov 20, 2026, Brainsway Ltd. (BWAY) is the stronger overall head-to-head candidate over ACOM (ACOM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BWAY carries a Unified Composite Score of 31.8/100 (SELL) at $8.48 (17.0x Forward P/E, 12.5% operating margin), whereas ACOM carries 53.3/100 (HOLD) at $21.74 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While ACOM currently prints a higher short-term Unified Composite Score (53.3/100 HOLD vs. BWAY 31.8/100 SELL), BWAY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (12.5% vs. N/A operating margin) and revenue trajectory (+35.4% vs. N/A YoY).
  • Technical & Structure Timing Caution: BWAY is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7); meanwhile ACOM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BWAY vs ACOM
BWAY NASDAQ Head-to-Head Winner
Brainsway Ltd. American Depositary Shares
Surgical & Medical Instruments & Apparatus
$8.48
-2.86% 1D
Market Cap $351.4M
TTM Revenue $108M
Forward P/E 17.0x
Beta / 30D Vol 1.84β · 66% Vol
Unified Composite Score
31.8 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -12.0%), weak momentum, RSI 28
RSI-14: 27.7 · SMA20: $10.57 · SMA50: $11.74
ACOM US Equity
ACOM
Institutional Equity
$21.74
-0.54% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.15β · 18% Vol
Unified Composite Score
53.3 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 65.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 25
RSI-14: 24.6 · SMA20: $23.11 · SMA50: $23.83

6-Pillar Scorecard Institutional Category Breakdown (BWAY 5 – 0 ACOM)

Columns: Metric · BWAY · ACOM
1. Valuation Multiples BWAY
Forward P/E 17.0x N/M
Trailing P/E 36.4x N/M
PEG Ratio N/M N/M
EV / Revenue 3.3x N/M
2. Growth & Scale BWAY
Revenue Growth (YoY) +35.4% N/A
Earnings Growth (YoY) +59.8% N/A
TTM Revenue (USD) $108M N/A
Market Cap $351.4M N/A
3. Profitability & Quality BWAY
Gross Margin 75.3% N/A
Operating Margin 12.5% N/A
Net Profit Margin 15.6% N/A
Return on Equity (ROE) 12.8% N/A
4. Balance Sheet & Cash Flow BWAY
Cash Generation (TTM) $15M EBITDA N/A
Cash Flow Margin 14.0% EBITDA Mgn N/A
Net Cash / Leverage $1.97 Book/Sh · 12.8% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 111.0% (77th %ile) N/A (N/A)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BWAY
OpEx & R&D Intensity 62.8% of Rev ($68M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BWAY (7) vs ACOM (3)
Institutional Metric BWAY ACOM Criterion Row Edge
Market Capitalization
Scale
$351.4M N/A Larger Scale BWAY
Trailing P/E Ratio
Valuation
36.4x N/M Lower Multiple BWAY
Forward P/E Ratio
Valuation
17.0x N/M Lower Multiple BWAY
Revenue Growth (YoY)
Growth
+35.4% N/A Higher Growth BWAY
Operating Margin (TTM)
Profitability
12.5% N/A Higher Margin BWAY
Net Profit Margin
Profitability
15.6% N/A Higher Margin BWAY
Return on Equity (ROE)
Capital Efficiency
12.8% N/A Higher ROE BWAY
52-Week Range Position
Momentum
0% ($8–$27) 44% ($19–$25) Stronger Trend ACOM
Beta / 30D Volatility
Risk Regime
1.84β · 66% Vol -0.15β · 18% Vol Lower Realized Risk ACOM
Unified Institutional Score
Composite Signal
31.8 / 100 (SELL) 53.3 / 100 (HOLD) Higher Composite ACOM
Trailing 12M Revenue (USD)
Operating Scale
$108M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
75.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$15M EBITDA ($1.97 Book/Sh · 12.8% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACOM +14.48 pp
BWAY: -25.87% · ACOM: -11.39%
3M Horizon ACOM +32.67 pp
BWAY: -40.24% · ACOM: -7.57%
6M Horizon ACOM +50.53 pp
BWAY: -41.15% · ACOM: +9.38%
1Y Horizon ACOM +50.53 pp
BWAY: -41.15% · ACOM: +9.38%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BWAY vs ACOM. Trailing 12-month operating profitability (BWAY 12.5% vs ACOM N/A) and valuation multiples (BWAY 17.0x vs ACOM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BWAY ADR TTM Benchmark FX-Normalized USD
TTM Revenue$108M
Gross Margin75.3%
Op. Margin12.5%
ROE / Fwd P/E12.8% · 17.0x
ACOM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BWAY UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 111.0%
IV Percentile 77th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BWAY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACOM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACOM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BWAY Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $351.4M market capitalization and 12.5% operating margin.
OpEx & R&D Reinvestment 62.8% of Rev ($68M)
90D Engineering Disclosures 0 Published
ACOM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BWAY vs ACOM Key Questions & Quantitative Answers

As of Nov 20, 2026, Brainsway Ltd. (BWAY) is the stronger overall head-to-head candidate over ACOM (ACOM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BWAY carries a Unified Composite Score of 31.8/100 (SELL) at $8.48 (17.0x Forward P/E, 12.5% operating margin), whereas ACOM carries 53.3/100 (HOLD) at $21.74 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ACOM currently prints a higher short-term Unified Composite Score (53.3/100 HOLD vs. BWAY 31.8/100 SELL), BWAY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (12.5% vs. N/A operating margin) and revenue trajectory (+35.4% vs. N/A YoY). Technical & Structure Timing Caution: BWAY is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7); meanwhile ACOM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BWAY leads the Growth & Scale pillar: BWAY posts +35.4% YoY revenue growth and +59.8% YoY earnings growth on $108M TTM revenue (75.3% gross margin, 12.5% operating margin), compared with ACOM at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BWAY generates $108M in USD-normalized revenue versus N/A for ACOM. In operating R&D and SG&A reinvestment, BWAY deploys 62.8% of Rev ($68M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ACOM.

BWAY screens cheaper on headline valuation multiples. BWAY trades at 17.0x Forward P/E, 36.4x Trailing P/E, N/M PEG, and 3.3x EV/Revenue (14.0% EBITDA margin), whereas ACOM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BWAY (12.8% ROE) versus ACOM (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, BWAY carries 111.0% implied volatility (77th %ile, Elevated (60th–80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.84β · 66% Vol realized risk). By comparison, ACOM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.15β · 18% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.